Awards Nomination
20+ Million Readerbase
PMC/PubMed Indexed Articles
Indexed In
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
James Beattie
James Beattie
Tanzania
Publications
-
Case Report
Neoadjuvant Vemurafenib for Borderline Resectable Metastatic Melanoma to Liver: A Case Report
Author(s): Yifei Sun, James Beattie, Harveshp Mogal and Eddy C. HsuehYifei Sun, James Beattie, Harveshp Mogal and Eddy C. Hsueh
Vemurafenib is a selective inhibitor of mutated B-Raf protein, which is found in 60% of metastatic melanoma. Neoadjuvant Vemurafenib for patient with metastatic melanoma, to decrease tumor size prior to surgical resection has been reported in patients with metastatic melanoma to the brain and lymph nodes. We present a case of neoadjuvant Vemurafenib in a patient with large borderline resectable metastatic melanoma to the liver. .. View More»
DOI: 10.4172/2157-2518.1000169